Patents by Inventor Pär Gellerfors

Pär Gellerfors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human porphobilinogen deaminase sequences
    Patent number: 6537777
    Abstract: A method for treatment or prophylaxis of disease caused by deficiency, in a subject, of an enzyme belonging to the heme biosynthetic pathway, the method comprising administering, to the subject, an effective amount of a catalyst which is an enzyme or an enzymatically equivalent part or analogue thereof. The disease is selected from the group consisting of acute intermittent porphyria (AIP), ALA deficiency porphyria (ADP), Porphyria cutanea tarda (PCT), Hereditary coproporphyria (HCP), Harderoporphyria (HDP), Variegata prophyria (VP), Congenital erthropoetic porphyria (CEP), Erythropoietic protoporphyria (EPP), and Hepatoerythropoietic porphyria (HEP).
    Type: Grant
    Filed: July 22, 1999
    Date of Patent: March 25, 2003
    Assignee: Hemebiotech A/S
    Inventors: Par Gellerfors, Jens Fogh
  • O-glycosylated IGF-1
    Patent number: 5273966
    Abstract: The present invention provides an O-Glycosylated Insulin-like Growth Factor 1 (IGF-1) analog of Insulin-like Growth Factor 1, a seventy amino acids single polypeptide chain which displays relatively high homology with proinsulin, essentially free from unglycosylated IGF-1.
    Type: Grant
    Filed: April 22, 1991
    Date of Patent: December 28, 1993
    Assignee: Kabi Pharmacia AB
    Inventors: Anna Sknottner-Lundin, Linda Fryklund, Par Gellerfors